Skip to main content

B 796 Pill - orange red capsule/oblong, 18mm

Pill with imprint B 796 is Orange / Red, Capsule/Oblong and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 796

Rivastigmine tartrate 6 mg B 796
Rivastigmine tartrate 6 mg B 796

Rivastigmine Tartrate

B 796
6 mg
Orange / Red
18.00 mm
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, magnesium stearate, microcrystalline cellulose, silicon dioxide, gelatin, titanium dioxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.